ASP Isotopes (NASDAQ:ASPI) Shares Up 7.8% – What’s Next?

ASP Isotopes Inc. (NASDAQ:ASPI) was up 7.8% on Friday . The company traded as high as $5.53 and last traded at $5.51. Approximately 2,210,445 shares traded hands during mid-day trading, a decline of 57% from the average daily volume of 5,136,980 shares. The stock had previously closed at $5.11.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on ASPI. Canaccord Genuity Group reiterated a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a report on Monday, November 24th. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, December 29th. Finally, Cantor Fitzgerald assumed coverage on shares of ASP Isotopes in a research report on Thursday, December 4th. They set an “overweight” rating and a $13.00 price target for the company. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $13.00.

ASP Isotopes Stock Up 5.7%

The company has a market capitalization of $598.54 million, a PE ratio of -4.15 and a beta of 3.55. The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14. The stock’s 50 day moving average is $6.22 and its 200 day moving average is $7.72.

Insider Buying and Selling at ASP Isotopes

In other ASP Isotopes news, CEO Robert Ainscow sold 8,438 shares of ASP Isotopes stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $6.20, for a total transaction of $52,315.60. Following the completion of the transaction, the chief executive officer owned 1,546,255 shares of the company’s stock, valued at $9,586,781. The trade was a 0.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Heather Kiessling sold 80,000 shares of the stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $5.80, for a total transaction of $464,000.00. Following the completion of the sale, the chief financial officer directly owned 732,500 shares in the company, valued at approximately $4,248,500. The trade was a 9.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 14.40% of the stock is currently owned by insiders.

Hedge Funds Weigh In On ASP Isotopes

Several hedge funds have recently bought and sold shares of the company. Quantbot Technologies LP purchased a new stake in ASP Isotopes in the 3rd quarter worth approximately $34,000. Ameritas Investment Partners Inc. grew its position in shares of ASP Isotopes by 41.2% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock valued at $40,000 after purchasing an additional 1,600 shares in the last quarter. BNP Paribas Financial Markets increased its holdings in shares of ASP Isotopes by 84.9% in the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after purchasing an additional 2,548 shares during the period. IFP Advisors Inc bought a new position in shares of ASP Isotopes in the fourth quarter worth $48,000. Finally, Pictet Asset Management Holding SA purchased a new stake in shares of ASP Isotopes in the fourth quarter worth $61,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.